Quarterly report pursuant to Section 13 or 15(d)

Subsequent Events

v3.22.2
Subsequent Events
6 Months Ended
Jun. 30, 2022
Subsequent Events [Abstract]  
Subsequent Events

12. Subsequent Events

 

Management has evaluated subsequent events occurring after June 30, 2022 through August 10, 2022, the date the unaudited condensed consolidated interim financial statements were available to be issued.

 

IDS Statement of Work No. 4

 

On July 8, 2022, Augmedix OpCo entered into Statement of Work No. 4 (“SOW No. 4”) with IDS Infotech Ltd. (“IDS”), pursuant to the Master Services Agreement, dated October 1, 2019, by and between the Subsidiary and IDS. SOW No. 4, among other things, terminates and replaces previous Statement of Work No. 3, dated August 1, 2021, by and between the Subsidiary and IDS, provides for an initial term of twelve (12) months beginning on the effective date of SOW No. 4, provides for the provision of remote medical documentation and clinical support services by IDS in accordance with SOW No. 4, and incorporates Augmedix Notes as a permanent part of the services provided by IDS.

 

Infosense Statement of Work No. 3

 

On July 11, 2022, Augmedix OpCo entered into a Statement of Work No. 3 (“SOW No. 3”) with Infosense Technologies, Pvt. Ltd. (“Infosense”), pursuant to the Master Services Agreement, dated February 1, 2018, by and between the Subsidiary and Infosense. SOW No. 3, among other things, terminates and replaces previous Statement of Work No. 2, dated July 1, 2020, by and between the Subsidiary and Infosense, provides for an initial term of twelve (12) months beginning on the effective date of SOW No. 3, provides for the provision of remote medical documentation and clinical support services by Infosense in accordance with SOW No. 3, and incorporates Augmedix Notes as a permanent part of the services provided by Infosense.